Followers | 40 |
Posts | 1920 |
Boards Moderated | 0 |
Alias Born | 11/08/2011 |
Tuesday, July 10, 2012 5:03:03 PM
Under the terms of the LOI, the companies had agreed to a 60-day option period during which they would negotiate a possible deal for RBCC to provide funding and expertise toward the development and marketing of one or more of Amarantus’ projects.
Funding
RBCC's latest financials (http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8409247 ) show they have $14k in cash - will this be enough to fund clinical trials?
Expertise
RBCC is an aquarium supply house and coral farm (their only source of revenue) that is pretending to somehow be a BioScience company. None of the two employees have any "expertise" to offer to AMBS as part of the contribution towards development of one (or more) of AMBS' projects.
This "possible" deal is never going to happen - to wish otherwise is simply naive.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM